SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 77.61+3.5%4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (1029)6/29/2005 4:29:23 PM
From: Jibacoa  Read Replies (1) of 3722
 
VICL Continued the uptrend that started on June 13 and is ready to test its March Hs

The stock was up another 8.49% today on volume of 239,270 On June 22 it went through the previously mentioned resistance at 4 and yesterday it went through its new resistance at 4.15 <g>

bigcharts.marketwatch.com

On its longer term chart, VICL still seems to have "potential".<g>

bigcharts.marketwatch.com

So far this month it has had several positive announcements, including:
A $12M order for its DNA vaccines against HIV from the VRC at NIAID;
The FDA designating its CMV Vaccine an "orphan drug"
And granting MRK the use of VICL technology in cancer vaccine applications, whuch should provide VICL with some $3M and possible milestone and royalty payments.

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext